FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

CONCLUSIONS: Early FDG PET/CT can identify metabolic changes in melanoma metastases that are potentially predictive of response to pembrolizumab and significantly correlated with PFS.PMID:38263597 | DOI:10.1158/1078-0432.CCR-23-2390

Source: Clinical Cancer Research - January 24, 2024 Category: Cancer & Oncology Authors: Thomas M Anderson Bryan H Chang Alexander C Huang Xiaowei Xu Daniel Yoon Catherine G Shang Rosemarie Mick Erin Schubert Suzanne McGettigan Kristin Kreider Wei Xu E John Wherry Lynn M Schuchter Ravi K Amaravadi Tara C Mitchell Michael D Farwell Source Type: research